Immediate Impact

59 standout
Sub-graph 1 of 21

Citing Papers

Pharmacological treatment for metabolic dysfunction–associated steatotic liver disease and related disorders: Current and emerging therapeutic options
2025 Standout
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
2024 Standout
1 intermediate paper

Works of Laura Reali being referenced

Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis
2014

Author Peers

Author Last Decade Papers Cites
Laura Reali 41 48 44 249 205 21 462
Stuart Astbury 16 38 54 169 275 25 531
Marco Poeta 17 39 32 266 147 33 571
Isabel Leiva‐Gea 28 17 38 91 185 35 436
Yanping Wan 20 54 119 188 149 43 570
Luis Macías‐Kauffer 23 12 42 124 250 23 441
Luca Pierri 12 17 39 212 144 24 437
Henrique Oswaldo da Gama Tôrres 42 13 37 107 152 20 413
Brett R. Loman 12 13 37 107 264 25 507
Stavros Pappas 36 29 57 184 47 27 537
Hong Yan 15 11 29 294 81 15 505

All Works

Loading papers...

Rankless by CCL
2026